drugset / Trial / NCT02612116

Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic Study

NCT02612116

Phase 4 Completed 49 enrolled Collegium Medicum w Bydgoszczy
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the differences in pharmacokinetics and pharmacodynamics of ticagrelor and its active metabolite depending on the strategy of the drug administration in patients with unstable angina pectoris.

Timeline

Start
2015-09
Primary completion
2016-08
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ticagrelor Small molecule 180 mg Other